SEC FORM 4
$984,750.00
Travere Therapeutics, Inc. (TVTX)
Acquisition (code M) of 39,000 shares at $25.25 per share.
Reporting Person ROTE WILLIAM E. · Officer Title Chief Research Officer · Transaction Code M
Traded Sep 15, 2026 · Disclosed Sep 17, 2026
Source: SEC Form 4 · 0001698262-26-000005 · filed 2026-09-17 · View filing →